8-K: DarioHealth Corp. Announces $6.824 Million Private Placement

DarioHealth Corp. has entered into securities purchase agreements for a private placement offering, raising approximately $6.824 million through the sale of Series D-2 and Series D-3 Preferred Stock.

Summary

• DarioHealth Corp. has entered into securities purchase agreements with accredited investors for a private placement.
• The offering involves the sale of 4,974 shares of Series D-2 Preferred Stock and 1,850 shares of Series D-3 Preferred Stock.
• The purchase price for each share of Preferred Stock is $1,000, resulting in aggregate gross proceeds of approximately $6,824,000 for the Company.
• The closing of the Preferred Stock sale is expected to occur on or before January 14, 2025.
• Each share of Preferred Stock is convertible into Common Stock at the holder's option, with an initial conversion price of $0.83, subject to adjustments.
• The conversion of the Preferred Stock is subject to stockholder approval.
• The Preferred Stock will automatically convert into shares of Common Stock on the 12-month anniversary of the issuance date, subject to certain beneficial ownership limitations.
• Holders of Preferred Stock will receive dividends equal to 10% of the Common Stock issuable upon conversion for each quarter anniversary of holding, for a total of four quarters.
• The Series D-2 Preferred Stock will vote with the Common Stock on an as-converted basis, while the Series D-3 Preferred Stock has no voting rights.
• In the event of liquidation, dissolution, or winding-up of the Company, Preferred Stock holders will be paid on a pari passu basis with other Parity Securities after the satisfaction of debts and Senior Securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The company is raising capital, which is generally positive, but the terms of the offering, including potential dilution and conversion limitations, temper the overall outlook.

Positives

• The private placement provides DarioHealth Corp. with $6.824 million in gross proceeds to be used for working capital and general corporate purposes.
• The conversion feature of the Preferred Stock could potentially lead to increased Common Stock ownership and liquidity.
• The dividend payments to Preferred Stock holders in the form of Common Stock could incentivize long-term investment.
• The offering is exempt from registration requirements, streamlining the process.

Negatives

• The conversion of Preferred Stock is subject to stockholder approval, which introduces uncertainty.
• The automatic conversion on the 12-month anniversary includes a 19.99% ownership blocker, potentially limiting the full conversion for some holders.
• The issuance of new shares upon conversion could dilute existing Common Stock holders.
• The Series D-3 Preferred Stock does not possess any voting rights with respect to such matters.

Risks

• The conversion of the Preferred Stock is subject to stockholder approval, and failure to obtain this approval could impact the value of the Preferred Stock.
• The market price of the Common Stock could be negatively impacted by the potential dilution from the conversion of the Preferred Stock.
• The Company's ability to meet its obligations under the securities purchase agreements is subject to various risks and uncertainties.
• The beneficial ownership limitations could restrict the ability of some holders to convert their Preferred Stock into Common Stock.

Future Outlook

The Company intends to use the net proceeds from the sale of the Securities for working capital and general corporate purposes. The Preferred Stock will automatically convert into Common Stock on the 12-month anniversary of the issuance date, subject to certain beneficial ownership limitations and stockholder approval.

Industry Context

Private placements are a common method for companies, especially smaller ones, to raise capital without the need for a full public offering. This allows for quicker access to funds, but often comes with terms that may be less favorable to existing shareholders, such as potential dilution.

Comparison to Industry Standards

• The conversion price of $0.83 is a key factor, and its attractiveness depends on the current and projected market price of DRIO's common stock.
• Similar companies raising capital through private placements often offer warrants or other sweeteners to attract investors, which doesn't appear to be the case here based on the document.
• The 10% dividend in shares is relatively standard for preferred stock offerings, but the lack of cash dividends might be a drawback for some investors.
• The 19.99% ownership blocker is a common provision to avoid triggering certain regulatory thresholds that would require additional filings or approvals.

Stakeholder Impact

• Shareholders may experience dilution upon conversion of the Preferred Stock.
• The capital raise could enable the Company to invest in growth initiatives, potentially benefiting employees and customers.
• The offering could impact the Company's financial stability, affecting its relationships with suppliers and creditors.

Next Steps

• The Company needs to close the private placement on or before January 14, 2025.
• The Company needs to file a Current Report on Form 8-K describing the terms of the transactions contemplated by this Agreement and disclosing any other material, nonpublic information.
• The Company needs to obtain stockholder approval for the conversion of the Preferred Stock.
• The Company needs to secure the listing of all of the Securities on the Nasdaq Capital Market with immediate effect upon the issuance of the Securities.
• The Company needs to file a registration statement on Form S-3 (or any other available form) providing for the resale by the Purchasers of the Conversion Shares and the shares of Common Stock issuable pursuant to the Lock Up Agreements.

Key Dates